Drug Type Small molecule drug |
Synonyms- |
Target |
Action agonists |
Mechanism NFE2L1 agonists(NFE2 like bZIP transcription factor 1 agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Neuroblastoma | Preclinical | Czechia | 01 Oct 2025 | |
| Neuroblastoma | Preclinical | Czechia | 01 Oct 2025 |





